0

Cardiology Collection
 281-300 of 4964 Articles
Ideas and Opinions |  2 June 2009
Glycemic Control in Type 2 Diabetes: Time for an Evidence-Based About-Face?
Victor M. Montori, MD, MSc; Mercè Fernández-Balsells, MD
Ann Intern Med. 2009;150(11):803-808. doi:10.7326/0003-4819-150-11-200906020-00008
Academia and the Profession |  2 June 2009
Advances in Measuring the Effect of Individual Predictors of Cardiovascular Risk: The Role of Reclassification Measures
Nancy R. Cook, ScD; Paul M Ridker, MD
Ann Intern Med. 2009;150(11):795-802. doi:10.7326/0003-4819-150-11-200906020-00007
Reviews |  2 June 2009
Meta-analysis: β-Blocker Dose, Heart Rate Reduction, and Death in Patients With Heart Failure
Finlay A. McAlister, MD, MSc; Natasha Wiebe, MMath, PStat; Justin A. Ezekowitz, MD, MSc; et al.
Ann Intern Med. 2009;150(11):784-794. doi:10.7326/0003-4819-150-11-200906020-00006
Reviews |  2 June 2009
Narrative Review: The Emerging Clinical Implications of the Role of Aldosterone in the Metabolic Syndrome and Resistant Hypertension
James R. Sowers, MD; Adam Whaley-Connell, DO; Murray Epstein, MD
Ann Intern Med. 2009;150(11):776-783. doi:10.7326/0003-4819-150-11-200906020-00005
Articles |  2 June 2009
Two Risk-Scoring Systems for Predicting Incident Diabetes Mellitus in U.S. Adults Age 45 to 64 Years
Henry S. Kahn, MD; Yiling J. Cheng, MD, PhD; Theodore J. Thompson, MS; et al.
Ann Intern Med. 2009;150(11):741-751. doi:10.7326/0003-4819-150-11-200906020-00002
Academia and the Profession |  19 May 2009
Current Guidelines for Using Angiotensin-Converting Enzyme Inhibitors and Angiotensin II–Receptor Antagonists in Chronic Kidney Disease: Is the Evidence Base Relevant to Older Adults?
Ann M. O'Hare, MD; James S. Kaufman, MD; Kenneth E. Covinsky, MD, MPH; et al.
Ann Intern Med. 2009;150(10):717-724. doi:10.7326/0003-4819-150-10-200905190-00010
Improving Patient Care |  19 May 2009
Shop for Quality or Volume? Volume, Quality, and Outcomes of Coronary Artery Bypass Surgery
Andrew D. Auerbach, MD, MPH; Joan F. Hilton, ScD; Judith Maselli, MSPH; et al.
Ann Intern Med. 2009;150(10):696-704. doi:10.7326/0003-4819-150-10-200905190-00007
Articles |  5 May 2009
Health Care–Associated Native Valve Endocarditis: Importance of Non-nosocomial Acquisition
Natividad Benito, MD, PhD; José M. Miró, MD, PhD; Elisa de Lazzari, MSs; et al.
Ann Intern Med. 2009;150(9):586-594. doi:10.7326/0003-4819-150-9-200905050-00004
Editorials |  21 April 2009 FREE
Communicating Drug Benefits and Risks Effectively: There Must Be a Better Way
Jerry Avorn, MD; William H. Shrank, MD, MSHS
Ann Intern Med. 2009;150(8):563-564. doi:10.7326/0003-4819-150-8-200904210-00012
Articles |  21 April 2009
Joint Effects of Common Genetic Variants on the Risk for Type 2 Diabetes in U.S. Men and Women of European Ancestry
Marilyn C. Cornelis, PhD; Lu Qi, MD, PhD; Cuilin Zhang, MD, PhD; et al.
Ann Intern Med. 2009;150(8):541-550. doi:10.7326/0003-4819-150-8-200904210-00008
Articles |  21 April 2009 FREE
Using a Drug Facts Box to Communicate Drug Benefits and Harms: Two Randomized Trials
Lisa M. Schwartz, MD, MS; Steven Woloshin, MD, MS; H. Gilbert Welch, MD, MPH
Ann Intern Med. 2009;150(8):516-527. doi:10.7326/0003-4819-150-8-200904210-00106
Articles |  21 April 2009 FREE
Differences in Control of Cardiovascular Disease and Diabetes by Race, Ethnicity, and Education: U.S. Trends From 1999 to 2006 and Effects of Medicare Coverage
J. Michael McWilliams, MD, PhD; Ellen Meara, PhD; Alan M. Zaslavsky, PhD; et al.
Ann Intern Med. 2009;150(8):505-515. doi:10.7326/0003-4819-150-8-200904210-00005
Editorials |  7 April 2009
The Future of Tobacco Treatment in the Health Care System
Nancy A. Rigotti, MD
Ann Intern Med. 2009;150(7):496-497. doi:10.7326/0003-4819-150-7-200904070-00011
Reviews |  7 April 2009
Systematic Review: Association of Low-Density Lipoprotein Subfractions With Cardiovascular Outcomes
Stanley Ip, MD; Alice H. Lichtenstein, ScD; Mei Chung, MPH; et al.
Ann Intern Med. 2009;150(7):474-484. doi:10.7326/0003-4819-150-7-200904070-00007
Articles |  7 April 2009
Triple-Combination Pharmacotherapy for Medically Ill Smokers: A Randomized Trial
Michael B. Steinberg, MD, MPH; Shelley Greenhaus, RN, MPH; Amy C. Schmelzer, MS; et al.
Ann Intern Med. 2009;150(7):447-454. doi:10.7326/0003-4819-150-7-200904070-00004
Articles |  7 April 2009
Effect of Varying Levels of Disease Management on Smoking Cessation: A Randomized Trial
Edward F. Ellerbeck, MD, MPH; Jonathan D. Mahnken, PhD; A. Paula Cupertino, PhD; et al.
Ann Intern Med. 2009;150(7):437-446. doi:10.7326/0003-4819-150-7-200904070-00003
Editorials |  17 March 2009 FREE
First Do No Harm … Reduction?
Marc N. Gourevitch, MD, MPH
Ann Intern Med. 2009;150(6):417-418. doi:10.7326/0003-4819-150-6-200903170-00111
Editorials |  17 March 2009
Aspirin for Prevention and Treatment of Cardiovascular Disease
Shamir R. Mehta, MD, MSc
Ann Intern Med. 2009;150(6):414-416. doi:10.7326/0003-4819-150-6-200903170-00011
Articles |  17 March 2009
Aspirin to Prevent Cardiovascular Disease: The Association of Aspirin Dose and Clopidogrel With Thrombosis and Bleeding
Steven R. Steinhubl, MD; Deepak L. Bhatt, MD, MPH; Danielle M. Brennan, MS; et al.
Ann Intern Med. 2009;150(6):379-386. doi:10.7326/0003-4819-150-6-200903170-00006
Articles |  3 March 2009
Factors Associated With Racial Differences in Myocardial Infarction Outcomes
John A. Spertus, MD, MPH; Philip G. Jones, MS; Frederick A. Masoudi, MD, MSPH; et al.
Ann Intern Med. 2009;150(5):314-324. doi:10.7326/0003-4819-150-5-200903030-00007
Advertisement
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)